Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Gemini Therapeutics Q2 EPS $(0.38) Up From $(0.44) YoY

Gemini Therapeutics (NASDAQ:GMTX) reported quarterly losses of $(0.38) per share. This is a 13.64 percent increase over losses of $(0.44) per share from the same period last year.
byBenzinga Newsdesk
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Gemini Therapeutics (NASDAQ:GMTX) reported quarterly losses of $(0.38) per share. This is a 13.64 percent increase over losses of $(0.44) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts